Finance

Beta
Lists
RENX:LON
Renalytix PLC
GBX 2.00
+11.11%
(+0.20) 1D
Jun 4, 4:30:00 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for RENX...
Open
GBX 1.76
High
GBX 2.00
Low
GBX 1.75
Mkt. cap
10.22M
Avg. vol.
814.93K
Volume
589.20K
52-wk high
GBX 15.50
52-wk low
GBX 1.60
EPS
-GBX 0.04
Shares outstanding
437.02M
No. of employees
46
Open
GBX 1.76
High
GBX 2.00
Low
GBX 1.75
Mkt. cap
10.22M
Avg. vol.
814.93K
Volume
589.20K
52-wk high
GBX 15.50
52-wk low
GBX 1.60
EPS
-GBX 0.04
Shares outstanding
437.02M
No. of employees
46
News stories
From sources across the web
About Renalytix PLC
CEO-
Employees46
Founded2018
Headquarters-
SectorHealth care
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
800.00K
800.00K
Cost of goods sold
-
-
400.00K
400.00K
Cost of revenue
-
-
400.00K
400.00K
Research and development expenses
-
-
300.00K
300.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
3.60M
3.60M
Operating expense
-
-
3.90M
3.90M
Total operating expenses
-
-
4.30M
4.30M
Operating income
-
-
-3.50M
-3.50M
Other non operating income
-
-
-10.00K
-10.00K
EBT including unusual items
-
-
-4.05M
-4.05M
EBT excluding unusual items
-
-
-3.90M
-3.90M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-4.05M
-4.05M
Net profit margin
-
-
-506.25%
-506.25%
Earnings per share
-
-
-
-
Interest and investment income
-
-
10.00K
10.00K
Interest expense
-
-
-200.00K
-200.00K
Net interest expenses
-
-
-190.00K
-190.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more